The effectiveness of EG treatment depended on the dose and the pretreatment time.<h4>Conclusion</h4>The oral treatment with EG could be a therapeutic strategy to prevent the action of Stx2 and the development of acute kidney injury in diarrhea-associated HUS patients. The gene discussed is STX2; the disease is hemolytic-uremic syndrome.